Systematic Review of the Quality of Patient Information on the Internet Regarding Inflammatory Bowel Disease Treatments Morgan Langille, André Bernard, Chris Rodgers, Stephanie Hughes, Des Leddin, Sander Veldhuyzen van Zanten Clinical Gastroenterology and Hepatology Volume 8, Issue 4, Pages 322-328 (April 2010) DOI: 10.1016/j.cgh.2009.12.024 Copyright © 2010 AGA Institute Terms and Conditions
Figure 1 Comparison of the DQS with the GQS for CD and UC websites. Range of DQS is 0–76, and GQS is 1–5. Clinical Gastroenterology and Hepatology 2010 8, 322-328DOI: (10.1016/j.cgh.2009.12.024) Copyright © 2010 AGA Institute Terms and Conditions
Figure 2 DQS for each CD or UC website depicting the proportion of points derived from each treatment option within each website. Clinical Gastroenterology and Hepatology 2010 8, 322-328DOI: (10.1016/j.cgh.2009.12.024) Copyright © 2010 AGA Institute Terms and Conditions
Figure 3 Number of websites (N = 43) containing information on CD or UC achieving at least 70% of the points on the DQS for an individual treatment option. 5-ASA, mesalamine; AZA, azathioprine. Clinical Gastroenterology and Hepatology 2010 8, 322-328DOI: (10.1016/j.cgh.2009.12.024) Copyright © 2010 AGA Institute Terms and Conditions
Figure 4 Correlation of the GQS with the average DISCERN score for websites containing information on the treatment options of CD and UC. Clinical Gastroenterology and Hepatology 2010 8, 322-328DOI: (10.1016/j.cgh.2009.12.024) Copyright © 2010 AGA Institute Terms and Conditions